91 related articles for article (PubMed ID: 23979195)
1. Personalized medicine: Lung Cancer leads the way.
Parikh P; Puri T
Indian J Cancer; 2013; 50(2):77-9. PubMed ID: 23979195
[No Abstract] [Full Text] [Related]
2. [Personalized medicine in non-small-cell carcinoma].
Iwama E; Takayama K; Baba E; Nakanishi Y
Fukuoka Igaku Zasshi; 2014 Mar; 105(3):57-66. PubMed ID: 25000657
[No Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.
Technol Eval Cent Assess Program Exec Summ; 2011 Mar; 25(6):1-5. PubMed ID: 21638942
[No Abstract] [Full Text] [Related]
4. Personalized medicine for non-small-cell lung cancer.
Mok TS; Zhou Q; Leung L; Loong HH
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
[TBL] [Abstract][Full Text] [Related]
5. Personalized targeted therapy in advanced non-small cell lung cancer.
Ma PC
Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS56-60. PubMed ID: 22614968
[TBL] [Abstract][Full Text] [Related]
6. Medicine. Why a new cancer drug works well, in some patients.
Marx J
Science; 2004 Apr; 304(5671):658-9. PubMed ID: 15118127
[No Abstract] [Full Text] [Related]
7. [Personalized treatment in non-small cell lung cancer].
Campos-Parra AD; Cruz-Rico G; Arrieta O
Rev Invest Clin; 2012; 64(4):377-86. PubMed ID: 23227588
[No Abstract] [Full Text] [Related]
8. Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer.
Heuckmann JM; Rauh D; Thomas RK
J Clin Oncol; 2012 Sep; 30(27):3417-20. PubMed ID: 22915655
[No Abstract] [Full Text] [Related]
9. The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.
Dowell JE; Minna JD
Nat Clin Pract Oncol; 2004 Nov; 1(1):2-3. PubMed ID: 16264773
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies.
Joshi VA; Kucherlapati R
Pharmacogenomics; 2007 Sep; 8(9):1211-20. PubMed ID: 17924836
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine for non-small-cell lung cancer.
Kucherlapati R
Oncology (Williston Park); 2010 Apr; 24(5):399-400. PubMed ID: 20480736
[No Abstract] [Full Text] [Related]
12. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer.
Kulesza P; Ramchandran K; Patel JD
Am J Clin Pathol; 2011 Aug; 136(2):228-38. PubMed ID: 21757595
[TBL] [Abstract][Full Text] [Related]
13. The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer.
Blackhall F; Thatcher N; Booton R; Kerr K
Lung Cancer; 2013 Feb; 79(2):101-3. PubMed ID: 23182148
[TBL] [Abstract][Full Text] [Related]
14. Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.
Cho D; Kocher O; Lee JC; Tenen DG; Meyerson ML; Janne PA; Halmos B
J Clin Oncol; 2005 Jan; 23(1):235-7. PubMed ID: 15625379
[No Abstract] [Full Text] [Related]
15. Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastases.
Kobayashi T; Takeda M; Marumo S; Koshimo Y; Teranishi T; Higami Y; Kato M
Lung Cancer; 2013 Apr; 80(1):109-11. PubMed ID: 23279871
[No Abstract] [Full Text] [Related]
16. Personalized therapy for non-small cell lung cancer: hype or clinical reality?
Wigle DA
Semin Thorac Cardiovasc Surg; 2011; 23(1):30-5. PubMed ID: 21807296
[No Abstract] [Full Text] [Related]
17. Gefitinib. Still no convincing results in non-small cell lung cancer.
Prescrire Int; 2010 Jun; 19(107):113. PubMed ID: 20738034
[No Abstract] [Full Text] [Related]
18. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
[No Abstract] [Full Text] [Related]
19. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
20. The tissue is the issue: personalized medicine for non-small cell lung cancer.
Hirsch FR; Wynes MW; Gandara DR; Bunn PA
Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
